All posts by imreal

Sensormatic Solutions Enhances its ShopperTrak COVID-19 Recovery Options with Unacast’s Mobility Data and Social Distancing Scoreboard


As the business world looks ahead to forecasting recovery, we’ve designed our insight offerings to help retailers guide critical decision making and planning in the most timely and accurate way possible.

Unacast, an award-winning location data and analytics firm, announced that it is making its Social Distancing Scoreboard and other mobility data insights available as part of the ShopperTrak brand offerings from Sensormatic Solutions, the leading global retail solutions portfolio of Johnson Controls. Sensormatic Solutions will include insights powered by Unacast’s Real World Graph® data engine, to help retailers protect its employees, customers, and assets in brick-and-mortar store operations and warehouses amid the COVID-19 pandemic.

Sensormatic Solutions is adding Unacast’s opt-in, location-based data as a complement to ShopperTrak’s in-store Market Intelligence traffic benchmarking to provide insights to when and where retail will recover by understanding consumer mobility patterns and people’s comfort with public spaces. Unacast’s Social Distancing Scoreboard is an easy to reference dashboard which layers statistics related to new reported cases with changes in mobility and non-essential store visits, providing daily community grades (A to F) to help retailers evaluate reopening individual store locations across their enterprise.

Unacast’s Social Distancing Scoreboard, launched in mid-March, has been widely adopted by business leaders, public health experts, policy makers, academics, and community leaders as a way to communicate the importance of social distancing, and to provide insights into current public behavior and unearth trends for future scenarios related to the spread of COVID-19 across states and counties in the United States. In addition to the US, Unacast recently expanded its toolkit to track social distancing behavior in more than 100 countries.

For its Social Distancing Scoreboard, Unacast applied geospatial human mobility insights with its proprietary tools to create an interactive map showing mobility trends by county or by state as a way to raise awareness of and reinforce the importance of social distancing in relation to slowing the spread of COVID-19. The Scorecard’s A through F letter grade for all states and counties in relation to social distancing behavior uses three metrics that are then compared to the number of new COVID-19 cases reported in those areas to assign letter grades to help users draw conclusions between social distancing behavior and virus spread over time.

Unacast’s Social Distancing Scoreboard provides three key metrics:


  • Change in distance traveled prior to COVID-19 in comparison to present-day (areas that observe at least a 70% decrease in average distance traveled are assigned a grade of A, while those that exhibit less than a 25% decrease or increase are assigned an F.);
  • Change in visitation to non-essential venues compared to a pre-COVID-19 period;
  • Change in human encounters, or the probability that two devices that were in the same place at the same time compared to a pre-COVID-19 period.

“We are honored to be included in Sensormatic’s offering to retailers along with ShopperTrak,” said Thomas Walle, CEO and Co-founder at Unacast. “We have seen how powerful our tools have been in helping businesses mitigate the pandemic spread. As the business world looks ahead to forecasting recovery, we’ve designed our insight offerings to help retailers guide critical decision making and planning in the most timely and accurate way possible.”

“As retailers look to restore consumer confidence in this new reality, our goal is to provide ways to understand shopper density within a store for compliance with social distancing guidelines or ordinances, and to meet maximum limits,” said Nick Pompa, global general manager, ShopperTrak. “We believe Unacast’s proprietary technology and approach can help our clients as they navigate an unprecedented and challenging business climate.”

Unacast developed the Covid-19 Toolkit with public datasets, as well as aggregate mobility and anonymous device data from tens of millions of devices. Unacast’s proprietary technology then extrapolates the results to show trends by county and by state. As with all Unacast technology, the Toolkit follows GDPR and CCPA guidelines.

About Unacast

Unacast is an award-winning human mobility data company that harnesses anonymous device location data, map data, and strategic intelligence to tackle business challenges for the retail, real estate, tourism, transportation, and marketing industries. With its flagship product “The Real World Graph®”, it provides innovative solutions and insights to operational challenges for companies of any size or shape. Unacast was founded in 2014 with offices in New York and Oslo, Norway. In 2019, Unacast was awarded the #1 small company to work in NYC for by Built In NYC and received Street Fights’ Most Innovative Use of Geospatial Technology award.

About Sensormatic Solutions

Sensormatic Solutions is the leading global retail solutions portfolio of Johnson Controls enabling smart and connected shopper engagement. By combining critical insights into retail inventory, shopper traffic and loss prevention, Sensormatic Solutions powers operational excellence at scale and helps create unique shopping experiences. Our solutions deliver real-time visibility and predictive analytics for accurate decision-making across the enterprise, enabling retailers to confidently move into the future. With more than 1.5 million data collection devices in the retail marketplace, we capture 40 billion shopper visits and track and protect billions of items each year. Our retail portfolio features the premier Sensormatic, ShopperTrak and TrueVUE brands. Please visit http://www.sensormatic.com, or follow us on LinkedIn, Twitter, and our YouTube channel.

For more information and the full portfolio of current Sensormatic Solutions products and offerings in response to COVID-19, please visit Sensormatic.com. Additional solutions are expected to be launched in the coming weeks as well.

© 2020 Johnson Controls. All Rights Reserved. SENSORMATIC, SHOPPERTRAK, TRUEVUE and the product names listed above are trademarks and/or registered trademarks. Unauthorized use is strictly prohibited.

Media Contacts:

Bianca Ilion

Kite Hill on behalf of Unacast

bianca@kitehillpr.com

Gay A Gagliardi

Sensormatic Solutions by Johnson Controls

Work +1 561-912-6750

gay.gagliardi@jci.com

Ryan Nolan

Johnson Controls

Work +1 414-524-6170

ryan.p.nolan@jci.com

Anne Lines

Matter on behalf of Sensormatic Solutions

Work + 1 978-518-4512

JCIretail@matternow.com

Share article on social media or email:

Dr. Mario Almanza Announces 5 Tips for Maximizing Your Weight Loss Post-Op Recovery


Dr. Mario Almanza

Dr. Mario Almanza

General Bariatric Surgeon Dr. Mario Almanza knows how effective procedures like gastric sleeve, gastric bypass and lap band surgery can be for enabling successful, long-term weight loss and the healthier, slimmer body patients deserve.

But Dr. Almanza also knows how important a healthy recovery process is to surgical success and how critical the right post-op behaviors are to achieving good health and sustained weight loss long after the patient has healed.

Below, Dr. Mario Almanza offers his take on what each weight loss patient should do during those important days and months after surgery – and how adhering to the right recovery plan can empower faster healing and make coping with post-op challenges just a little bit easier.

1. Speak with your bariatric care team before going home:

Dr. Mario Almanza has performed thousands of weight-loss surgeries. And after each procedure, Dr. Almanza and his team have taken great care to supply each patient with the information they need to enjoy the safest recovery possible.

Once your surgery is over, be sure to consult with your bariatric physician about everything you’ll need to optimize healing and avoid potential side effects. Ask any/all questions you have about recovery, what you’ll need to eat (post-op diet) and what resources are out there to make the process smoother.

2. Adhere to your medication plan:

As Dr. Almanza knows, the level of discomfort and pain patients experience post-op is highly personalized, depending largely on such factors as the type of bariatric procedure performed, the individual patient’s level of pain tolerance and their unique state of health.

But regardless of the situation, Dr. Mario Almanza recommends sticking to the pain management plan prescribed by the physician, and speaking out if pain and discomfort persist in spite of the medication. Doing so allows your bariatric team to monitor your progress and prescribe solutions when things don’t appear to be working.

3. Prevent complications by following instructions:

Bariatric surgery is generally pretty safe. Still, it’s crucial to adhere to any/all post-op instructions your surgical team provides to minimize complications that can hinder a successful recovery.

Dr. Mario Almanza recommends following each post-op instruction to the letter throughout your recovery, no matter how banal or unnecessary any steps may seem.

4. Optimize your at-home recovery environment:

Once you leave the hospital or post-op ward, it’s important to have a comfortable at-home environment to return to and begin your recovery process.

Dr. Almanza and his team recommend arranging such an environment beforehand and ensuring you have the post-op foods, entertainment options and comfy bed/couch areas ready once you’re given the green light to go home.

5. Stay in touch with your physician:

As Dr. Mario Almanza knows, sticking to follow-up appointments and updating your physician on your progress are critical to achieving a successful recovery. Be sure to consult your doctor should you experience any abnormal post-op swelling, illness or side effects, and always ask questions when needed.

About: Dr. Mario Almanza is a leading gastric sleeve surgeon in Tijuana. To date, Dr. Almanza has successfully performed more than 16,000 bariatric procedures.

Contact:

Dr. Mario Almanza

General Bariatric Surgeon; Laparoscopic Bariatric Surgeon

Phone: (855) 753-3833

Web: https://www.marioalmanza.com/

Share article on social media or email:

Catalent Signs Development Agreement with Ennaid Therapeutics on its COVID-19 Lead Program


During this pandemic we have seen that numerous companies are looking to repurpose existing antiviral drugs to target COVID-19, and we are supporting our development partners in reacting quickly and effectively to manufacture material for clinical trials

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced a collaboration with Ennaid Therapeutics to develop an oral, antiviral treatment targeted at COVID-19. Under the terms of the agreement, Catalent will develop a powder-in-capsule formulation of Ennaid’s ENU200 program, a patent-pending, repurposed oral antiviral drug.

ENU200 was selected by Ennaid as a candidate to treat COVID-19 following a bioinformatic search for in silico identification of prior-approved chemical compounds blocking the coronavirus proteins, spike-S glycoprotein and the key coronavirus enzyme, Mpro. Catalent’s development site at San Diego will manufacture roller-compacted formulations of ENU200 within capsules for further investigation.

“During this pandemic we have seen that numerous companies are looking to repurpose existing antiviral drugs to target COVID-19, and we are supporting our development partners in reacting quickly and effectively to manufacture material for clinical trials,” commented Jonathan Arnold, President, Oral and Specialty Delivery at Catalent. “Our experience with similar formulation and manufacturing processes and overcoming scale up challenges with roller compaction has meant that we are able to rapidly deliver Ennaid’s demand for drug product in a matter of weeks.”

Catalent’s San Diego facility is one of three global centers of excellence in early-phase development focusing on preclinical to clinical Phase 2b formulation, analytical, and manufacturing solutions for orally delivered small molecules, the other two being located in Somerset, New Jersey and Nottingham, U.K. The three strategically-located sites are closely connected to the company’s clinical supply services network, to optimize the transition from finished dose manufacture to clinical packaging and distribution.

About Catalent

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs over 13,500 people, including over 2,400 scientists and technicians, at more than 40 facilities, and in fiscal year 2019 generated over $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

About Ennaid Therapeutics

Ennaid is a specialty pharmaceutical company using state-of-the-art artificial intelligence-based drug discovery platforms to develop broad-spectrum antiviral drugs that treat diseases in the Flaviviridae and Coronaviridae family of viruses, specifically SARS-CoV-2, the virus that causes COVID-19. The company has identified 112 additional compounds that may treat COVID-19 and other coronaviruses. Since inception, Ennaid has focused on the treatment of mosquito-borne diseases including Zika virus and dengue virus, which have caused pandemics. Their pipeline includes twelve additional indications. These programs were entering preclinical testing and have been placed on hold so that Ennaid can focus on developing a COVID-19 therapeutic. For more information visit, http://www.ennaidthera.com.

Share article on social media or email:

Austin Dental Implant Center Provides Consultations for Dental Implant Procedures in Austin, TX at No Cost


Dr. Dan Holtzclaw, Dental Implant Specialist in Austin, TX

Dr. Dan Holtzclaw Offers Complimentary Dental Impant Consultations for Austin, TX

I didn’t even have much pain afterward at all. It’s incredible. It will change your life immensely.

Austin Dental Implant Center offers complimentary consultations for dental implant procedures to those with damaged or missing teeth in Austin, TX. This practice offers care from some of the most experienced dental implant specialists in the world. Even those with the complex missing teeth cases have an increased chance of eligibility for permanent tooth replacement at Austin Dental Implant Center, and can confirm what treatments are available to them in a consultation at no cost.

Completing thousands of dental implant placements every year, the Austin Dental Implant Center doctors are highly skilled and experienced. The practice features an in-house laboratory full of world-class Zirkonzahn™ technology and a team of doctors that specialize in each aspect of the dental implant procedure, so patients can receive their entire treatment under one roof, and often in just one appointment.

Because of their expertise in implantology, the doctors at Austin Dental Implant Center offer dental implant procedures that require extremely advanced skill and experience, rare to most doctors in the industry. The practice is one of few in the nation to offer zygomatic dental implants, and one of even fewer to provide pterygoid dental implants for patients with severe bone loss. They also have designed their own patented full mouth dental implant procedure, DIAsmile™.

With DIAsmile™, patients are able to replace an entire mouth of missing teeth with just one appointment. The DIAsmile™ treatment includes surgery, sedation, prosthetic restoration, and even extra implant posts, if needed, at no additional cost. With DIAsmile™, patients receive a complete, beautiful smile in one day, restoring their confidence and their ability to eat and speak clearly without discomfort.

“I had both arches done in the same day, so I didn’t have to come back for another procedure,” says Travis, a Austin Dental Implant Center patient who received full mouth dental implants. “I didn’t even have much pain afterward at all. It’s incredible. It will change your life immensely.”

Those with failing or missing teeth who are interested in receiving one of the cutting-edge dental implant procedures available at Austin Dental Implant Center are invited to come in for a cost-free consultation. To schedule an appointment, call 512-375-0050 or visit http://www.austindentalimplantcenter.com.

About the Practice

Austin Dental Implant Center was founded by Dr. Dan Holtzclaw, one of the world’s leading authorities on full arch immediately loaded dental implant treatment. Using experience from thousands of dental implant procedures, Dr. Holtzclaw pioneered the DIAsmile™ implant teeth-in-a-day treatment concept, which allows patients to receive a new dental implant smile in just one day. With an in-house laboratory utilizing world-class Zirkonzahn™ technology, staff oral surgeons, staff prosthodontists, and experienced dental technicians, Austin Dental Implant Center is able to provide industry leading dental implant treatment in one convenient location, eliminating the need for patients to travel to multiple offices, as is required with most traditional dental offices. To learn more about the Austin Dental Implant Center advantage visit http://www.austindentalimplantcenter.com or call 512-375-0050.

Share article on social media or email:

Choosing the Best Passive Thermal Packaging Solution for Clinical Trial Products, Upcoming Webinar Hosted by Xtalks


Xtalks Life Science Webinars

Solutions should consider several factors including thermal performance, system cost, freight and payload optimization, pack-out simplicity and physical performance.

The expansive growth and regulation of temperature-sensitive distribution has led to an overwhelming number of thermal packaging solutions available on the market today and choosing the best fit has become increasingly challenging. Protecting temperature-sensitive products is paramount but overdesigning a packaging solution that is able to withstand 100% of any possible weather event results in bulky, heavy and expensive systems. Under-designing systems with low component costs will run the risk of experiencing failures in transit. Choosing the proper passive thermal packaging will allow efficiencies and accuracy in maintaining temperature and optimizing spend.

The growth of cold chain distribution, especially with biologics and biosimilars, is expected to continue to grow exponentially. Increasing global regulations have led to greater scrutiny of the temperature-sensitive supply chain process including packaging, temperature monitoring and logistics, which can result in higher distribution costs. Protecting these high-value products properly and at the lowest total cost has become imperative to maintain or grow market share in the competitive global marketplace.

Solutions should consider several factors including thermal performance, system cost, freight and payload optimization, pack-out simplicity and physical performance. Another factor to consider is the environmental impact of shippers and could a reusable shipper option be a viable and cost-effective solution for cold chain distribution?

Join Thomas Johnson, Clinical Distribution Manager, PCI Clinical Trial Services and Paul Della Villa, Business Unit Manager, Reusable Solutions, Cold Chain Technologies in a live webinar on Thursday, May 28, 2020 at 11am EDT (4pm BST/UK).

For more information or to register for this event, visit Choosing the Best Passive Thermal Packaging Solution for Clinical Trial Products.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Access Healthcare Services Successfully Mobilizes Global Workforce


Access Healthcare associates working from home.

Access Healthcare associates working from home.

“Contrary to what many businesses fear when considering offshoring their revenue cycle management, we experienced order, concern, dedication, and employees rising above and beyond our expectations.” – Shaji Ravi, President & Managing Director, India

Dallas-based Access Healthcare Services USA LLC, specialists in healthcare revenue cycle management and IT services, with more than 12,000 employees worldwide, achieved the seemingly impossible task of mobilizing their employees in India and the Philippines to both home and remote work environments in less than 48-hours at the onset of nation-wide mandated office shutdowns during the COVID-19 pandemic. Company executives credit the swift execution of their 4-stage emergency action plan to the company’s culture of strong leadership, client service conviction, employee dedication, and proprietary technology solutions.

As early as February, Shaji Ravi, Access Healthcare’s President and Managing Director based in India was convinced that work from home orders were imminent in both India and the Philippines. This requirement would have a significant negative impact on the economies of India and the Philippines, as these countries are home to a large number of offshore delivery centers for many global companies. In mid-March, David Tassoni, President of U.S. Operations for Access Healthcare, initiated discussions with senior management about the company’s emergency action plan that would mitigate the looming client service delivery and continuity of business challenges due to the expanding COVID-19 pandemic. Management concern was two-fold: the continuing delivery of high-quality services to their healthcare clients; and, to support and maintain the company’s 12,000 person workforce (in 13 delivery centers in India and 4 centers in the Philippines), both while being productive and compliant under COVID-19 restrictions.

The Access Covid-19 Action Plan prioritized frequent communication and engagement with all clients worldwide, mobilizing the workforce to new locations in less than 48 hours and deploying a virtual-office hierarchical management strategy. The work-from-home blueprint is atypical in these countries, especially in the revenue cycle management industry, due to asset security, legal concerns, HIPPA constraints, mobility of computer hardware, and availability of internet service in rural areas. Access Healthcare’s legal teams worked closely with clients to communicate steps being taken under the company’s COVID-19 action plan, the impact on existing terms and conditions, if any, and related mitigation plans.

Heartwarming stories of perseverance and innovation emerged amidst the new remote working mandate. The populations of India and the Philippines often live in multi-generational homes consisting of 800 to 1000 square feet of living space. Some of the remote workers in rural locations would strategically locate their home workspace where they could attain best internet service, which could often times disrupt the typical household routine. Family members graciously adjusted their own schedules to accommodate the Access Healthcare security requirements. The company compensated remote employees for power and internet services at home, as well as providing data cards to those areas with limited broadband connectivity.

“India and the Philippines were impacted enormously,” said Ravi, “A new way of conducting business was conceived and executed within 48 hours. Contrary to what many businesses fear when considering offshoring their revenue cycle management, we experienced order, concern, dedication, and employees rising above and beyond our expectations. We want our clients and prospects to know this is a reliable, safe and effective business model.”

Currently 99% of the production staff is remote access capable and are operating at over 90% of normal production capacity. The next and final step to operation mobilization will be the gradual and phased return to the delivery centers in the large cities once the lockdown mandate expires.

Access Healthcare’s senior management sees their proprietary technology, systems and loyal workforce as their strength. Interestingly, the firm has experienced growth during the COVID-19 pandemic and has even continued their recruitment process, conducting new-hire interviews and testing via Zoom. The newest class of recruits is currently onboarding and training virtually.

Chairman Anurag Jain anticipates increased capital investment in technology and automation for many companies on the near horizon. Following this crisis, he believes the nimble companies will consider their core capabilities, and outsource many secondary functions.

“There will be other crises, no doubt,” says Jain. “Pandemics, severe weather events, unstable governments – I’m very pleased with our company’s response to COVID-19, and believe we are well positioned for the future.”

http://www.accesshealthcare.com

# # #

Share article on social media or email:

Star Refrigeration Urges Customers to Maintain Legal Compliance


Star is continuing to provide on site maintenance support.

“Star is committed to carrying out the necessary inspections and taking corrective actions to support our customers and provide continuity throughout this challenging time.”

Star is advising customers that it is crucial to consider ongoing legislation relating to the safe operation of refrigeration and HVAC equipment. The Health & Safety Executive (HSE) recently stipulated the need for duty holders to remain compliant with regulations during the COVID-19 lockdown.

In line with government guidance, Star is carrying out vital service work for existing customers, to ensure continuity and compliance with refrigeration industry regulations. Star is also providing critical repair and maintenance services to essential industries during the COVID-19 pandemic.

Star Refrigeration Operations Director James Ward says: “We are continuing to undertake all essential maintenance work to ensure the smooth running of equipment and compliance with HSE regulations. Despite the current circumstances, it is important that plant operators continue to meet ongoing legal requirements.”

James Ward adds: “Star is committed to carrying out the necessary inspections and taking corrective actions to support our customers and provide continuity throughout this challenging time.”

Star’s nationwide refrigeration engineering team is continuing to operate in order to provide an essential support service for food production, processing, storage and distribution. Throughout the lockdown, Star has also provided critical repair and maintenance for cooling systems in key industries, including healthcare and IT/communication.

Star is UK’s largest refrigeration engineering company, with over 100 field engineering staff currently in operation across the UK during the COVID-19 pandemic. Star is working carefully within government guidelines to provide on site maintenance support, whilst ensuring the safety of staff, customers and the wider community.

Share article on social media or email:

Asymmetrex Presents Benefits of Stem Cell Counting at Clinical Trial Supply Conference


Benefits of Stem Cell Counting

Asymmetrex Presents the Benefits of Stem Cell Counting for Stem-Gene Clinical Trial Supply

If the FDA is starting to insist that that we have stem cell-specific dose for therapies, for clinical trials we are going to need it for supply as well.

On May 12, the director of stem cell biotechnology company Asymmetrex continued to demonstrate the reach of his company’s tissue stem cell counting technology into all aspects of the stem cell regenerative medicine industry. Speaking online in Arena International’s Clinical Trial Supply 2020 conference, James Sherley, M.D., Ph.D. outlined how achieving a more effective supply chain for stem-gene therapy clinical trials will require the industry to advance to certification of the stem cell-specific properties of transported cell and gene therapies. Because of disruptions caused by the current global COVID19 crisis, this year’s annual conference was organized as a virtual experience online.

Asymmetrex’s AlphaSTEM Test™ technology is the first and only technology that can specifically quantity therapeutic tissue stem cells. The technology is applicable to therapies deploying either natural or genetically-engineered tissue stem cells. In his presentation, Sherley highlighted the prevalent misconception that therapeutic tissue stem cells can be counted by flow cytometry. Tissue stem cells cannot be counted by flow cytometry. Counting by flow cytometry requires biomarkers that specifically identify tissue stem cells. To date, despite years of attempts, such biomarkers have not been discovered.

In an earlier podcast series on “Counting Stem Cells” featured on the international stem cell industry networking platform RegMedNet, Sherley discussed the benefits of Asymmetrex’s technology to stem-gene therapy patients by providing essential dose information for their treatments. In his clinical trial supply presentation, he related the importance of the same care in ensuring that the potency and quality of stem cell treatments are preserved during transport for supply of stem-gene clinical trials.

Sherley also alerted his clinical trial supply audience to recent developments on the FDA regulatory landscape that are likely to impact future supply practices for stem-gene clinical trials. “If the FDA is starting to insist that that we have stem cell-specific dose for therapies, for clinical trials we are going to need it for supply as well.” Sherley based this prediction on a recent industry document developed by the FDA’s Standards Coordinating Body’s that identifies determination of unknown cell-specific doses as a needed standard for regenerative medicine.

About Asymmetrex

Asymmetrex, LLC is a Massachusetts life sciences company with a focus on developing technologies to advance stem cell medicine. Asymmetrex’s founder and director, James L. Sherley, M.D., Ph.D. is an internationally recognized expert on the unique properties of adult tissue stem cells. The company’s U.S. and U.K. patent portfolio contains biotechnologies that solve the two main technical problems – production and quantification – that have stood in the way of successful commercialization of human adult tissue stem cells for regenerative medicine and drug development. In addition, the portfolio includes novel technologies for isolating cancer stem cells and producing induced pluripotent stem cells for disease research purposes. Asymmetrex markets the first technology for determination of the dose and quality of tissue stem cell preparations (the “AlphaSTEM Test™”) for use in stem cell transplantation therapies and pre-clinical drug evaluations. Asymmetrex is a member company of the Advanced Regenerative Manufacturing Institute BioFabUSA and the Massachusetts Biotechnology Council.

Share article on social media or email:

Compliancy Group is Listed On Inc. Magazine’s Best Workplaces for 2020


INC best places to work

INC best places to work

“One thing we pride ourselves most on is our ability to preserve our corporate culture as we grow. Our team is our most valuable asset and we are truly like a family. Our evolution demonstrates what it takes to build a successful brand while still keeping a family-like culture.”

Compliancy Group is listed as one of Inc. Magazine’s Best Workplaces for 2020. Inc. analyzed data from more than 3,000 submissions, and chose 395 finalists for this year’s list. Compliancy Group’s employees took part in an employee survey, conducted by Quantum Workplace, on topics including trust, management effectiveness, perks, and confidence in the future. Inc. gathered, analyzed, and audited the data.

The strongest engagement scores came from companies that prioritize the most human elements of work. These Companies are leading the way in employee recognition, performance management, and diversity.

“One thing we pride ourselves most on is our ability to preserve our corporate culture as we grow. Our team is our most valuable asset and we are truly like a family. Our evolution demonstrates what it takes to build a successful brand while still keeping a family-like culture. Management is not only involved in employees’ professional success, but also invests in personal growth. This gives each employee the opportunity to grow within the company, love what they do, and express that through to our clients. Compliancy Group is an amazing place to work because it feels like home and I truly believe that everyone here feels the same way,” Marc Haskelson, CEO Compliancy Group.

“Building a great corporate culture comes only from strong leadership,” says Inc. magazine editor-in-chief Scott Omelianuk. “The companies on Inc.’s Best Workplaces list are setting an example that the whole country can learn from, especially now, when company culture is more important to the workforce than ever.

More from Compliancy Group:

Downloadable Content:

HIPAA News

Free HIPAA Compliance Checklist

Protected Health Information

What is a Business Associate

Compliance Software

About Compliancy Group:

HIPAA should be simple. That’s why Compliancy Group is the only HIPAA software with expert Compliance Coaches holding your hand to simplify compliance. Built by auditors, Compliancy Group gives you confidence in your compliance plan to reduce risk, increase patient loyalty, and profitability of your organization.

Why Compliancy Group?

HIPAA Audit Support, no client has ever failed an audit!

Total Solution

HIPAA Seal of Compliance

Dedicated Compliance Coaches

Visit https://www.compliancy-group.com or call 855.854.4722 to learn how simple compliance can be.

About Inc. Media:

The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning multi platform content reaches more than 50 million people each month across a variety of channels including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers, and the credibility that helps them drive sales and recruit talent. The associated Inc. 5000 Conference is part of a highly acclaimed portfolio of bespoke events produced byInc. For more information, visit http://www.inc.com.

About Quantum Workplace Quantum Workplace, based in Omaha, Nebraska, is an HR technology company that serves organizations through employee-engagement surveys, action-planning tools, exit surveys, peer-to-peer recognition, performance evaluations, goal tracking, and leadership assessment. For more information, visit QuantumWorkplace.com.

Share article on social media or email:

Shady Grove Fertility (SGF) Atlanta Resumes Full-Service Fertility Procedures and Treatments May 11, 2020


Drs. Desireé McCarthy-Keith, Anne Namnoum, Mark Perloe, and Pavna Brahma of Shady Grove Fertility Atlanta.

Patient, staff and community safety are of paramount importance, especially now. We’ve implemented new safety precautions at nearly every step of the patient experience. So while this is not business as usual, our commitment to help those struggling to conceive is strong and steadfast.

SGF, a pioneer in reproductive medicine, research, and innovation, and home to more than 85,000 babies born, announced today that SGF Atlanta has resumed all fertility procedures and treatments in its Atlanta, GA, location. While its Alpharetta, Buckhead-Piedmont, and Marietta offices remain closed temporarily, all Greater Atlanta area patients may start or resume full-service fertility care.

“Patient, staff and community safety are of paramount importance, especially now. We’ve implemented new safety precautions at nearly every step of the patient experience. So while this is not business as usual, our commitment to help those struggling to conceive is strong and steadfast,” said Pavna Brahma, M.D., of SGF’s Atlanta-Northside and Buckhead-Piedmont locations.

SGF Fertility Treatments Now Available in Georgia

Comprehensive fertility services, such as fertility and ovarian reserve testing and diagnosis, semen analysis, a full range of fertility treatments such as ovulation induction and intrauterine insemination (IUI), and cycle monitoring, in vitro fertilization (IVF), donor egg, sperm, and embryo treatment, genetic screening and testing, IVF for inherited genetic disease prevention, gestational carrier, egg freezing, fertility preservation for patients with cancer, and LGBTQ family building are all currently available at SGF Atlanta.

Patients seeking a fertility consult with an SGF physician may do so using during a secure, private video consult. “We have found the new video consults offer a uniquely intimate way of getting to know our patients during that first consult. For most, it’s a more comfortable and convenient experience being able to get questions answered and chart a plan for moving forward from comfort of their own home,” shared Anne Namnoum, M.D., of SGF’s Atlanta-Northside office.

“We are so inspired by the strength and endurance shown by our community during these uncertain times, and we recognize that while much of our world has been put on hold, our patients’ desire to have a baby remains. With improvements to safety and physical distancing protocols in place, we are overjoyed that our patients can again move forward with their family building goals at SGF,” said Mark Perloe, M.D., of SGF’s Atlanta-Northside office.

Read more about SGF’s safety protocols.

SGF Atlanta’s Physician Team Recognized as Top Docs

The SGF Atlanta team is recognized as Top Doctors for Infertility by Atlanta Magazine and operates under the leadership of Dr. Desireé McCarthy-Keith, SGF Atlanta’s Medical Director. SGF Atlanta brings significant advantages to patients. Recognized by Aetna’s Institutes of Excellence™ as well as being named a Center of Excellence by Optum,™ patients in Atlanta not only benefit from SGF’s extensive insurance participation but also exclusive financial programs that make accessing quality fertility care more affordable. (SGF Atlanta earned the distinction of Center of Excellence by demonstrating successful clinical outcomes and exceptional physician experience, staffing, and facilities, as well as maintaining accreditation status and continuous quality assurance.)

SGF Atlanta, home to Dr. McCarthy-Keith and fellow physicians, Drs. Anne Namnoum, Mark Perloe, and Pavna Brahma, has also earned numerous accolades in the region including Best Reproductive Endocrinology Practice by Kudzu—a distinction earned through a voting process by members of the surrounding Atlanta community.

SGF Atlanta is accepting new patients. Call 1-877-761-1967 or submit this brief form to schedule a virtual physician consult.

About Shady Grove Fertility (SGF)

SGF is a leading fertility and IVF center of excellence with more than 85,000 babies born and counting. With 38 locations throughout FL, GA, MD, NY, PA, VA, D.C., and Santiago, Chile, we offer patients virtual physician consults, individualized care, accept most insurance plans, and make treatment affordable through innovative financial options, including treatment guarantees. More physicians refer their patients to SGF than any other center. Call 1-888-761-1967 or visit ShadyGroveFertility.com.

Share article on social media or email: